Thursday, November 20, 2014

Today's Datapoint


11% is the annual rate of growth projected through 2020 for the sale of orphan drugs in the U.S., compared to approximately 4% for drugs that treat larger populations, according to the EvaluatePharma Orphan Drug Report 2014, from Evaluate Ltd.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)